Townsend Raymond R
Renal Division, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Curr Opin Nephrol Hypertens. 2015 Jan;24(1):47-53. doi: 10.1097/MNH.0000000000000086.
The purpose of this review is to highlight what the Chronic Renal Insufficiency Cohort (CRIC) study has taught us regarding arterial stiffness in chronic kidney disease. The CRIC study began in mid-2003 and enrolled more than 3900 people with chronic kidney disease.
The recent findings from the CRIC study are covered in 10 lessons. Within the CRIC study, we enrolled about 2800 participants who underwent a pulse wave velocity measurement. At the time of initial funding, very little was known about the role of arterial stiffness in chronic, nondialyzed, kidney disease. The lessons span the gamut from simple correlations to measures such as central arterial pressure profiles and reproducibility of pulse wave velocity measurements between operators, to relationships of pulse wave velocity to kidney function, protein excretion, cardiovascular disease prevalence, and incident cardiovascular events such as heart failure.
The implications from these lessons are that pulse wave velocity is a robust, reproducible measure of arterial stiffness which adds important information to standard clinical assessments such as SBP and DBP in a population with chronic kidney disease, a disorder with high likelihood of progressive kidney function loss, and a substantial predisposition to cardiovascular disease.
本综述旨在强调慢性肾功能不全队列(CRIC)研究在慢性肾脏病动脉僵硬度方面给我们的启示。CRIC研究始于2003年年中,招募了3900多名慢性肾脏病患者。
CRIC研究的最新发现包含10个要点。在CRIC研究中,我们招募了约2800名接受脉搏波速度测量的参与者。在最初获得资助时,人们对动脉僵硬度在慢性非透析肾脏病中的作用知之甚少。这些要点涵盖了从简单相关性到诸如中心动脉压曲线以及不同操作者间脉搏波速度测量的可重复性等测量方法,再到脉搏波速度与肾功能、蛋白质排泄、心血管疾病患病率以及诸如心力衰竭等心血管事件发生率之间的关系。
这些要点的意义在于,脉搏波速度是一种可靠、可重复的动脉僵硬度测量指标,它为慢性肾脏病患者的标准临床评估(如收缩压和舒张压)增添了重要信息。慢性肾脏病患者有肾功能进行性丧失的高风险,且极易患心血管疾病。